Drugmakers agree to participate in second round of price negotiations
All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals , whose medicines are part of the second round of ...
pharmaphorum7y
FDA approves Teva's Huntington's Disease drug
The FDA has approved Teva’s Huntington’s Disease drug, the first new treatment for the neurological disease in almost a decade. The FDA has approved Austedo (deutetrabenazine) tablets for the ...
Drug Store News27d
Axsome, Teva settle litigation over Auvelity
Axsome will grant Teva a license to sell its generic version of Auvelity beginning on or after March 31, 2039, if pediatric exclusivity is granted, or on or after Sept. 30, 2038, if no pediatric ...
Seeking Alpha29d
Teva and Alvotech get FDA review acceptance for its proposed biosimilar to Eylea
Alvotech (NASDAQ:ALVO) and Teva Pharmaceuticals (NYSE:TEVA) said on Tuesday that the U.S. FDA has accepted for review a Biologics License Application for a biosimilar targeting Regeneron’s (REGN ...